Filter by category
- All
- Blog
- Congress
- Scientific resource
- Webinar
- Poster
- Scientific publication
- Press release
- Press coverage
- News
Filter by category
Blog
17/10/2023
Targeted RNA degradation: Principle and Therapeutic Promises
RNA, or RiboNucleic Acid, is a structured macromolecule which plays a central role in numerous cellular functions.
Congress
02/10/2023
EORTC International Conference on Molecular Targets and Cancer Therapeutics
Oncodesign Services will be attending to EORTC 2023 ! Fix a meeting now.
27/09/2023
Meet Marie!
Every day, as an invivo research technician, Marie participates in the in vivo studies and tests the effects of a new molecule or a new product. Discover her journey and learn more about working in a lab as a technician.
Blog
19/09/2023
Breaking Barriers in Oncology Drug Development: Unveiling the Potential of 3D Cell Models for Drug Discovery
Blog: 3D Cell models are revolutionizing Cancer Drug Development. Here, we present the main advantages to better understand tumor complexity
Scientific publication
24/07/2023
Leucettinibs, a Class of DYRK/CLK Kinase Inhibitors Inspired by the Marine Sponge Natural Product Leucettamine B
Dual-specificity, tyrosine phosphorylation-regulated kinases (DYRKs) and cdc2-like kinases (CLKs) recently attracted attention due to their central involvement in various pathologies.
Blog
11/07/2023
CADD: computer tools and chemists combine to make better drug leads
Sylvain Lozano, computational chemist, explains the important role these tools play in our drug discovery journey.
News
05/07/2023
Oncodesign Services receives global excellence awards
Oncodesign Services is thrilled to announce that we have been awarded 'Best Preclinical Services & Drug Discovery Company 2023 – France!
Blog
29/06/2023
Why you should consider tumor microenvironment for cancer therapy?
Combination of Tumor microenvironment and modulating therapeutic approaches may be required to overcome the resistance to treatments and prevent tumor recurrence.
Press release
27/06/2023
Oncodesign Services announce access to ImaginAb’s CD8 ImmunoPET technology
Oncodesign Services announces the execution of a Preclinical License and Supply Agreement with ImaginAb Inc.
Webinar
19/06/2023
[EN] Kinase Inhibitors for Inflammatory Diseases: Preclinical Development
Join the featured speakers for an informative webinar on unlocking the synergy in preclinical models and the importance of target validation for the personalized treatment of pancreatic cancer.
Blog
15/06/2023
How to mimic long COVID for drug discovery?
Long COVID is a complex multisystemic condition still poorly understood. Using optimal preclinical models is essential to understand their mechanisms better and develop new treatments.
News
22/05/2023
Oncodesign Services and Veritas In Silico enter into business cooperation
Oncodesign Services and Veritas In Silico Inc. announced that they have entered into a Memorandum of Understanding to respond to the needs of pharmaceutical companies seeking to develop innovative small molecule drugs targeting messenger RNA.